Mengjuan Wei

674 total citations
25 papers, 522 citations indexed

About

Mengjuan Wei is a scholar working on Epidemiology, Molecular Biology and Pharmacology. According to data from OpenAlex, Mengjuan Wei has authored 25 papers receiving a total of 522 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Epidemiology, 11 papers in Molecular Biology and 9 papers in Pharmacology. Recurrent topics in Mengjuan Wei's work include Liver Disease Diagnosis and Treatment (11 papers), Drug-Induced Hepatotoxicity and Protection (8 papers) and Genomics, phytochemicals, and oxidative stress (4 papers). Mengjuan Wei is often cited by papers focused on Liver Disease Diagnosis and Treatment (11 papers), Drug-Induced Hepatotoxicity and Protection (8 papers) and Genomics, phytochemicals, and oxidative stress (4 papers). Mengjuan Wei collaborates with scholars based in China. Mengjuan Wei's co-authors include Lili Ji, Liang Shi, Bin Lü, Shaobo Zhang, Zhenlin Huang, Zhengtao Wang, Zhiyong Zheng, Jin Yao, Feifei Hu and Yuchen Sheng and has published in prestigious journals such as Free Radical Biology and Medicine, Biochemical Pharmacology and Journal of Ethnopharmacology.

In The Last Decade

Mengjuan Wei

24 papers receiving 519 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mengjuan Wei China 12 227 147 146 72 70 25 522
Xuyang Dai China 9 182 0.8× 101 0.7× 145 1.0× 70 1.0× 57 0.8× 10 439
Maysa A. Mobasher Saudi Arabia 12 211 0.9× 114 0.8× 79 0.5× 39 0.5× 48 0.7× 32 514
Michael Atef Fawzy Egypt 14 197 0.9× 106 0.7× 80 0.5× 60 0.8× 51 0.7× 42 566
Naihua Hu China 9 181 0.8× 98 0.7× 141 1.0× 36 0.5× 52 0.7× 11 425
Shu-Ju Wu Taiwan 10 199 0.9× 121 0.8× 115 0.8× 34 0.5× 55 0.8× 10 438
Pin‐Ho Pan Taiwan 12 171 0.8× 116 0.8× 117 0.8× 31 0.4× 56 0.8× 15 480
Yue‐Rong Ma China 9 159 0.7× 111 0.8× 124 0.8× 52 0.7× 114 1.6× 15 476
Yinxiao Jiang China 12 161 0.7× 122 0.8× 139 1.0× 52 0.7× 59 0.8× 17 489
Ching‐Fen Wu Germany 15 201 0.9× 93 0.6× 89 0.6× 56 0.8× 79 1.1× 19 475

Countries citing papers authored by Mengjuan Wei

Since Specialization
Citations

This map shows the geographic impact of Mengjuan Wei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mengjuan Wei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mengjuan Wei more than expected).

Fields of papers citing papers by Mengjuan Wei

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mengjuan Wei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mengjuan Wei. The network helps show where Mengjuan Wei may publish in the future.

Co-authorship network of co-authors of Mengjuan Wei

This figure shows the co-authorship network connecting the top 25 collaborators of Mengjuan Wei. A scholar is included among the top collaborators of Mengjuan Wei based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mengjuan Wei. Mengjuan Wei is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zou, Yu, et al.. (2025). Biochemical biomarkers for the toxicity induced by Traditional Chinese Medicine: A review update. Journal of Ethnopharmacology. 341. 119315–119315. 1 indexed citations
2.
Wang, Congrong, Yan Wang, Chengcheng Huang, et al.. (2025). The role of dysregulated copper metabolism in diabetes and its complications: a review. Frontiers in Endocrinology. 16. 1681001–1681001. 1 indexed citations
3.
Guo, Qian, Keke Wang, Mengjuan Wei, et al.. (2024). Forsythiaside-A improved bile-duct-ligation-induced liver fibrosis in mice: The involvement of alleviating mitochondrial damage and ferroptosis in hepatocytes via activating Nrf2. Free Radical Biology and Medicine. 222. 27–40. 5 indexed citations
4.
5.
Luo, Dan, et al.. (2024). No causal association between serum vitamin D levels and diabetes retinopathy: A Mendelian randomization analysis. Nutrition Metabolism and Cardiovascular Diseases. 34(5). 1295–1304. 3 indexed citations
6.
Wei, Mengjuan, Tianyu Zhang, Hao Ouyang, et al.. (2023). Erianin alleviated liver steatosis by enhancing Nrf2-mediated VE-cadherin expression in vascular endothelium. European Journal of Pharmacology. 950. 175744–175744. 3 indexed citations
7.
Wei, Mengjuan, Feifei Hu, Hao Ouyang, et al.. (2023). Chlorogenic acid ameliorated non-alcoholic steatohepatitis via alleviating hepatic inflammation initiated by LPS/TLR4/MyD88 signaling pathway. Chemico-Biological Interactions. 376. 110461–110461. 17 indexed citations
8.
9.
Wei, Mengjuan, et al.. (2023). Chlorogenic acids: A pharmacological systematic review on their hepatoprotective effects. Phytomedicine. 118. 154961–154961. 34 indexed citations
10.
Wei, Mengjuan, Zhiyong Zheng, Yuchen Sheng, et al.. (2023). EGR1 is crucial for the chlorogenic acid–provided promotion on liver regeneration and repair after APAP-induced liver injury. Cell Biology and Toxicology. 39(6). 2685–2707. 11 indexed citations
11.
Zhang, Hong, et al.. (2023). Exploring the efficacy and mechanism of Glycyrrhizae Radix et Rhizoma in improving collagen-induced arthritis in mice. Journal of Ethnopharmacology. 322. 117554–117554. 6 indexed citations
12.
Wei, Mengjuan, Yi Zhang, Hong Zhang, et al.. (2022). HMGB1 induced endothelial to mesenchymal transition in liver fibrosis: The key regulation of early growth response factor 1. Biochimica et Biophysica Acta (BBA) - General Subjects. 1866(10). 130202–130202. 15 indexed citations
13.
Wei, Mengjuan, et al.. (2022). Integrating network pharmacology approach and experimental validation to reveal the alleviation of Shenkangning capsule on chronic nephritis. Journal of Ethnopharmacology. 299. 115676–115676. 8 indexed citations
14.
Miao, Hui, Hao Ouyang, Qian Guo, et al.. (2022). Chlorogenic acid alleviated liver fibrosis in methionine and choline deficient diet-induced nonalcoholic steatohepatitis in mice and its mechanism. The Journal of Nutritional Biochemistry. 106. 109020–109020. 38 indexed citations
15.
Zhao, Qing, Mengjuan Wei, Shaobo Zhang, et al.. (2020). The water extract of Sophorae tonkinensis Radix et Rhizoma alleviates non-alcoholic fatty liver disease and its mechanism. Phytomedicine. 77. 153270–153270. 14 indexed citations
16.
Hu, Feifei, Qian Guo, Mengjuan Wei, et al.. (2020). Chlorogenic acid alleviates acetaminophen-induced liver injury in mice via regulating Nrf2-mediated HSP60-initiated liver inflammation. European Journal of Pharmacology. 883. 173286–173286. 37 indexed citations
17.
Shi, Liang, Shaobo Zhang, Zhenlin Huang, et al.. (2020). Baicalin promotes liver regeneration after acetaminophen-induced liver injury by inducing NLRP3 inflammasome activation. Free Radical Biology and Medicine. 160. 163–177. 63 indexed citations
18.
Yang, Fan, Li Li, Rui Yang, et al.. (2019). Identification of serum microRNAs as potential toxicological biomarkers for toosendanin-induced liver injury in mice. Phytomedicine. 58. 152867–152867. 26 indexed citations
19.
Shi, Liang, Shaobo Zhang, Mengjuan Wei, et al.. (2018). Baicalein and baicalin alleviate acetaminophen-induced liver injury by activating Nrf2 antioxidative pathway: The involvement of ERK1/2 and PKC. Biochemical Pharmacology. 150. 9–23. 120 indexed citations
20.
Yang, Rui, Mengjuan Wei, Fan Yang, Yuchen Sheng, & Lili Ji. (2018). Diosbulbin B induced G2/M cell cycle arrest in hepatocytes by miRNA-186-3p and miRNA-378a-5p-mediated the decreased expression of CDK1. Toxicology and Applied Pharmacology. 357. 1–9. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuyang Dai Breakdown of academic impact, for papers by Maysa A. Mobasher Breakdown of academic impact, for papers by Michael Atef Fawzy Breakdown of academic impact, for papers by Naihua Hu Breakdown of academic impact, for papers by Shu-Ju Wu Breakdown of academic impact, for papers by Pin‐Ho Pan Breakdown of academic impact, for papers by Yue‐Rong Ma Breakdown of academic impact, for papers by Yinxiao Jiang Breakdown of academic impact, for papers by Ching‐Fen Wu
Rankless by CCL
2026